{"nctId":"NCT01976416","briefTitle":"Novel Use Of Hydroxyurea in an African Region With Malaria","startDateStruct":{"date":"2014-09"},"conditions":["Sickle Cell Anemia","Sickle Cell Disease","Malaria"],"count":208,"armGroups":[{"label":"Hydroxyurea","type":"EXPERIMENTAL","interventionNames":["Drug: Hydroxyurea"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Hydroxyurea","otherNames":["Siklos","Hydroxycarbamide"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Pediatric subjects with documented sickle cell anemia (HbSS supported by hemoglobin electrophoresis or by peripheral blood smear showing sickled red blood cells)\n* Age range of 1.00-3.99 years, inclusive, at the time of enrollment\n* Weight at least 5.0 kg at the time of enrollment\n* Willingness to comply with all study-related treatments, evaluations, and follow up\n\nExclusion Criteria:\n\n* Known chronic medical condition (e.g., HIV, malignancy, active clinical tuberculosis)\n* Severe malnutrition determined by impaired growth parameters as defined by WHO (weight for length/height or weight-for-length/height \\> 3 z-scores below the median WHO growth standards)\n* Pre-existing severe hematological toxicity:\n\n  1. Hb \\<4.0 g/dL\n  2. Hb \\<6.0 g/dL AND ARC \\<100 x 10E9/L\n  3. Hb \\<7.0 g/dL AND ARC \\<80 x 10E9/L\n  4. Platelets \\<80 x 10E9/L\n  5. ANC \\<1.0 x 10E9/L\n* Alanine transaminase (ALT) or creatinine \\>2 times the upper limit of normal for age\n* Blood transfusion within 30 days prior to enrollment","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Months","maximumAge":"47 Months","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Malaria Episodes","description":"Malaria is defined as the presence of P. falciparum or P. malariae on the peripheral smear of any child brought in for medical evaluation of fever. P. vivax, P. ovale and P. knowlesi are not known to be present in this region, but if a child is seen with suspected infection with any of these malaria parasites, this will also be recorded as a case of malaria. Incidence will be reported in the number of cases per 100 patient years.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":104},"commonTop":["Upper Respiratory Tract Infection","Vaso-Occlusive Crisis","Anemia","Pneumonia","Gastrointestinal-related"]}}}